If you need more information, please contact us by phone.
Liver tumors, albeit arising from diverse origins, are all the result of an uncontrolled growth...
In the past several weeks, Deputy Head of Medical Oncology at Humanitas and Professor of...
In Italy only 10% of the diagnoses of liver cancer occur at an early stage...
From 11 to 15 April, Paris hosted the annual meeting of the European Association for...
The annual meeting of the European Association for the Study of the Liver (EASL) took...
"Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a...
“Multicentre Treatment Planning Inter-comparison in a National Context. The Liver Stereotactic Ablative Radiotherapy case”. This...